Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia

    NEXT STORY
    The Global Ultrasound Image Analysis Software Market is expected to grow from USD 483.49 Million in 2018 to USD 1,289.03 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.03%
    PREV STORY
    UPS Supporting NYC Healthcare Workers, First Responders & Community Organizations Amid Coronavirus Pandemic
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    IBA SA : IBA signs three new Proteus®ONE contracts with Proton Partners International

    IBA signs three new Proteus®ONE contracts with Proton Partners International IBA to install three ...

    author_avatar
    NASDAQ Market News

    ADMA Biologics to Present at Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News

    Cyclerion Therapeutics Announces Praliciguat Topline Phase 2 Results in Diabetic Nephropathy

    author_avatar
    NASDAQ Market News